Assembly Biosciences Inc expected to post a loss of 29 cents a share - Earnings Preview

Assembly Biosciences

04/08/2023 16:22

* Assembly Biosciences Inc  ASMB.OQ   ASMB.O  is expected
to show
no change in quarterly revenue when it reports  results on
August 7 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Assembly
Biosciences Inc
is for a loss of 29 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Assembly
Biosciences Inc is $2.5​, above​ its last closing price
of $1.11. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.36       -0.35      -0.37     Missed  -4.2
 Dec. 31 2023              -0.45      -0.46     Missed  -2.2
 Sep. 30 2022  -0.40       -0.47      -0.48     Missed  -2.1​
 Jun. 30 2022  -0.48       -0.47      -0.51     Missed  -9.4
 ​​Mar.        -0.57       -0.47      -0.48     Missed  -1.1
 31 2022                                                
 Dec. 31 2021  -0.51       -0.48      -0.38     Beat    20.4​
 Sep. 30 2021  -0.55       -0.56      -0.41     Beat    26.6
 Jun. 30 2021  -0.65       -0.66      -0.55     Beat    16.2
 This summary was machine generated August 4 at 15:22 GMT.  All
figures in US dollars  unless otherwise stated